Work

A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Digestion

DOI: 10.1159/000150632

Authors: K. Matsueda, S. Harasawa, M. Hongo, N. Hiwatashi, D. Sasaki

Institutions: Kohnodai Hospital, National Center for Global Health and Medicine, Saiseikai Kawaguchi General Hospital, Tohoku University Hospital, Iwaki Kyoritsu General Hospital, Hirosaki University

Language: English

Topic: Gastrointestinal motility and disorders

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2017232891

FWCI: 7.38

Cites: 14

Cited by: 87

Related to: 10